https://www.avient.com/sites/default/files/2020-09/versaflex-pf-final.pdf
VersaflexTM PF
Versaflex PF
VOC
Versaflex PF
VERSAFLEX PF
VOC
39 LDPE / 13 Versaflex PF
VERSAFLEX PF
39 LDPE / 13 Versaflex PF
N
/
2
5
m
m
N
/
2
5
m
m
F = 25 ° C 7 I = 25 ° C 20
MD6741 / MD6700
VERSAFLEX PF
TM
+86 021 60284888
www.avient.com
VERSAFLEX™ PF
1 CF6751 PP
2 2420K LDPE
Versaflex™ PF
MD6727
Versaflex™ PF
MD6741
Versaflex™ CF
6751
Versaflex™ PF
MD6649
Versaflex™ PF
9512
Versaflex™ CF
8888N-A
Versaflex™ PF
MD6666
Versaflex™ PF
MD6748
Versaflex™ PF
MD6700
Versaflex™ CF
9000
PP
PVC
Tg (°C) -26 -43 -30 -26 -5 1 -6 0 5 /
(Shore A) 50 49 35 37 38 35 37 31 30 19
MFI (190°C, 2.16kg)
(g/10min)
/ / / 15 5 15 20 3 5 27
MFI (230°C, 2.16kg) 8 20 8 / / / / / / /
1 LDPE 2420k2/LDPE 2420k/Versaflex™ =4.5/4.5/1 ; =50um
(N/25mm)
25°C 20 1.3 1.8 7.9 2.5 2.2 2.7 3.3 3.0 3.7 4.3
75°C 7 5.7 2.9 7.2 3.1 4.0 4.3 4.3 5.5 5.6 /
PMMA
(N/25mm)
25°C 20 1.8 2.0 7.2 2.6 2.8 3.0 3.6 3.3 3.9 4.9
75°C 7 5.5 4.7 7.1 3.5 / 4.7 6.5 5.8 6.9 /
https://www.avient.com/sites/default/files/2021-10/remafin-ep-white-masterbatches-for-pharma-application-bulletin_0.pdf
FDA/EU compliance information available upon request
REMAFIN™ EP White Colorants
for Pharmaceutical Packaging
REMAFIN™ EP is a range of PE and PP based
masterbatches designed for protecting oral,
topical, parenteral, ophthalmic and nasal
pharmaceuticals by opacifying primary and
secondarypharmaceutical packaging.
KEY CHARACTERISTICS
• Manufactured under change control principles
beyond CAS number (similar level as MEVOPUR
concentrates), reducing risk of change
• Free from animal-derived substances and
phthalates
• Suitable for blown film, injection molding,
blow molding and extrusion
REGULATORY SUPPORT
• Raw materials tested to:
- ISO 10993-1
- USP chapters , including Class VI,
a requirement for ophthalmic and nasal drugs
- European Pharmacopeia 3.1.3/3.1.5
(polyolefin)
- USP (polyethylene)
- ICH Q3D elemental impurities
- USP and USP light transmission
• Registered Drug Master File (Type III)
• Food contact compliance established with
FDA/EU*
APPLICATION BULLETIN
CARRIER
MATERIAL
PIGMENT
CONTENT/TYPE
LIGHT
FASTNESS
THERMAL
STABILITY
PRODUCT
CODE
HDPE 50% TiO2 8 300°C PH00075525
LLDPE 60% TiO2 8 300°C PL00075542
LLDPE 70% TiO2 8 300°C PL00075545
PP 50% TiO2 8 300°C PP00075717
Healthcare use limitations apply—see below.
Without limiting the generality of this statement, Avient products shall not be used in any medical device application intended for:
(1) exposure to human tissue or body fluids for 30 days or greater;
(2) “plastic” (cosmetic or reconstructive) surgery use;
(3) reproductive implants or any birth control device; or
(4) any critical component in a permanently (greater than 30 days) implanted medical device that supports or sustains human life.
https://www.avient.com/resources/safety-data-sheets?page=2730
PP LT.
GRV-PS-018-BA-NAT
ICU GREEN PP
https://www.avient.com/resources/safety-data-sheets?page=1278
PG 59749.00 PEARL RD PP
GRV-TE-094-W-NAT
PP FR 8-6 LMS-1000
https://www.avient.com/resources/safety-data-sheets?page=1687
X GRV-15640-01-2
PP WHITE
PP BLUE
https://www.avient.com/resources/safety-data-sheets?page=1438
PG 532150.02 RD PP
UV PURPLE PP
GRV-UR-077-W-NAT
https://www.avient.com/resources/safety-data-sheets?page=1592
Pearl Moon White (PP)
GRV-NY-032-CU-NAT
PP FR 8-6 LMS-1000
https://www.avient.com/resources/safety-data-sheets?page=1524
GRV-NY-037-W-SS-BLK
PG 71050.00 RD PP
PG 164101.01 WT PP
https://www.avient.com/sites/default/files/2020-10/excelite-im-product-bulletin-americas-1.pdf
In
fact, case studies have shown scrap rates can be
reduced from 30% to less than 1%.
PP, PE,
PS, PVC
No Good
Foam PP
Better, larger cells with lower cell
density in standard IM processes;
suitable for cell nucleation in
structural foam processing
PP, PE,
PS, PVC
Yes Better
FA-110
Best cell structure with higher cell
density; provides better structural
integrity and lower density in
standard IM processes
PP, PE,
PS, PVC
Yes Best
KEY CHARACTERISTICS
Excelite IM formulations provide
injection molders with:
• Material density and weight reduction
• High concentration of active CFA
• Improved distribution of CFA into
polymer matrix
• High cell density with tight cell structure
• Control over consistency and accuracy
• Reduced sink marks
• Ability to improve flow of material
• Cycle time reduction
• Improved dimensional stability
• Improved thermal insulation
EXCELITE IM – PRODUCT FORMULATIONS
www.avient.com
Copyright © 2020, Avient Corporation.
https://www.avient.com/investor-center/news/avient-announces-second-quarter-2024-results
June 30
June 30
June 30